Mazor Surgical Technologies Ltd announced that it has received approval from the ethical committee (Helsinki) of a leading hospital in Israel (Sheba) to begin human clinical trial with the Mazor proprietary GO-LIF surgical procedure and implants. This approval allows surgeons to use GO-LIF procedure and Mazor proprietary screws in patients undergoing spinal fixation surgery. Mazor expects this study to demonstrate that the GO-LIF procedure is safe and efficacious leading to improve surgical outcome compared to current procedures. T he GO-LIF procedure is an innovative spine surgical procedure developed by Mazor and in partnership with the Cleveland Clinic Foundation, according to the strategic agreement signed in April 2008. This procedure enables spinal fixation by insertion of proprietary GO-LIF implants into the patient’s spine in a minimally invasive surgical technique and accurate guidance enabled by SpineAssist, Mazor’s miniature robotic device. The GO-LIF clinical study will include additional surgeons and hospitals in 8 medical centers in Israel, Germany and later on in the US, pending additional Helsinki and IRB approvals.